Skip to main content
. 2024 Jul 14;16(7):939. doi: 10.3390/pharmaceutics16070939
ADCC Antibody-dependent cell-mediated cytotoxicity
APCs Antigen-presenting cells
CRS Cytokine release syndrome
DDS Drug delivery system
HLA-E Human leukocyte antigen-E
IFN-γ Interferon-γ
IL-12R Interleukin 12 receptor
IL-15 Interleukin 15
IL-15R Interleukin 15 receptor
IL-18R Interleukin 18 receptor
IL-21R Interleukin 21 receptor
IL-2R Interleukin 2 receptor
ISs Immune synapses
KIRs Killer cell immunoglobulin-like receptors
MHC Major histocompatibility complex
MHT Mild magnetothermal therapy
NCAM Neural cell adhesion molecule
NCR1 Natural cytotoxic triggering receptor 1
NEO NK-derived exosomes
NK Natural killer
NKG2A Natural Killer Group 2A
PBMCs Peripheral blood monocytes
PD-1 Programmed death 1
PDA Polydopamine
PS Phosphatidylserine
ROS Reactive oxygen species
siRNAs Small interfering nucleic acids
Tim-3 T-cell immunoglobulin and mucin domain Containing protein-3
TNFR Tumor necrosis factor receptor
TNF-α Tumor necrosis factor-α
Tregs Inhibiting regulatory T cells
ULBPs UL16-binding proteins